In This Section
- Home
- Research & Innovation
- Stories with Impact
- College Team
- Programmes
- Hospital Partners
- Community Partners
- Jennings Gallery
- Graduate Studies
- Programmes for International (Non-EU) Students
- Interprofessional Learning (IPL)
- Dr Ashleigh Byrne-O’Brien Memorial Fund & Awards
- iEd Hub
- Inaugural Professorial Lecture Series
- Learning, Teaching & Curriculum
- Philanthropic Lectures
- UCC Academic Health Sciences
- Continuing Professional Development
New study reveals breast cancer drug combination has impact on other cancers
4 Mar 2024
- Drug commonly used to treat HER2-positive breast cancer sees tumour shrinkage in several other cancer types.
- Cancer treatment combination may have more uses than previously thought.